Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2010
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: This study was conducted in accordance with international guidelines and in accordance with GLP. All relevant validity criteria were met.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2011

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
Deviations:
no
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
UK GLP Monitoring authority
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Reference substance name:
Fatty acids, C18-unsatd., reaction products with acrylic acid and polyethylenepolyamines
EC Number:
287-820-4
EC Name:
Fatty acids, C18-unsatd., reaction products with acrylic acid and polyethylenepolyamines
Cas Number:
85586-18-1
Molecular formula:
Not applicable (a generic molecular formula cannot be provided for this specific UVCB substance)
IUPAC Name:
(Z,9Z)-N-(2-{2-[(8Z)-heptadec-8-en-1-yl]-4,5-dihydro-1H-imidazol-1-yl}ethyl)octadec-9-enimidic acid; 3-[(2-carboxyethyl)({2-[3-(2-carboxyethyl)-2-[(8Z)-heptadec-8-en-1-yl]imidazolidin-1-yl]ethyl})amino]propanoic acid; 3-{2-[(8Z)-heptadec-8-en-1-yl]-3-{2-[(E)-[(9Z)-1-hydroxyoctadec-9-en-1-ylidene]amino]ethyl}imidazolidin-1-yl}propanoic acid

Method

Target gene:
Histidine and Tryptophan synthesis genes
Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation:
with and without
Metabolic activation system:
S9 prepared from the livers of male rats treated with 80/100 mg Phenobarbitone/B-naphthoflavone
Test concentrations with justification for top dose:
Preliminary test: 0.15, 0.5, 1.5, 5, 15, 50, 150, 500, 1500 and 5000 ug/plate for Salmonella strains TA100, TA1535, TA98 (presence of S9) and E. Coli strain WP2uvrA- (Absence and presence of S9)

Definitive test: 5, 15, 50, 150, 500, 1500, 5000ug/plate for Salmonella strains TA100, TA1535, TA98 (absence of S9) and TA1537 (Absence and presence of S9)
Vehicle / solvent:
Sterile distilled water
Controlsopen allclose all
Untreated negative controls:
no
Negative solvent / vehicle controls:
no
True negative controls:
no
Positive controls:
yes
Positive control substance:
N-ethyl-N-nitro-N-nitrosoguanidine
Remarks:
2 ug/plate for WP2uvrA- without S9
Untreated negative controls:
no
Negative solvent / vehicle controls:
no
True negative controls:
no
Positive controls:
yes
Positive control substance:
N-ethyl-N-nitro-N-nitrosoguanidine
Remarks:
3 ug/plate for TA100 without S9
Untreated negative controls:
no
Negative solvent / vehicle controls:
no
True negative controls:
no
Positive controls:
yes
Positive control substance:
N-ethyl-N-nitro-N-nitrosoguanidine
Remarks:
5 ug/plate for TA1535 without S9
Untreated negative controls:
no
Negative solvent / vehicle controls:
no
True negative controls:
no
Positive controls:
yes
Positive control substance:
9-aminoacridine
Remarks:
80 ug/plate for TA1537 without S9
Untreated negative controls:
no
Negative solvent / vehicle controls:
no
True negative controls:
no
Positive controls:
yes
Positive control substance:
4-nitroquinoline-N-oxide
Remarks:
0.2 ug/plate for TA98 without S9
Untreated negative controls:
no
Negative solvent / vehicle controls:
no
True negative controls:
no
Positive controls:
yes
Positive control substance:
other:
Remarks:
2-Aminoanthracene 1ug/plate for TA100 with S9
Untreated negative controls:
no
Negative solvent / vehicle controls:
no
True negative controls:
no
Positive controls:
yes
Positive control substance:
other:
Remarks:
2-Aminoanthracene 2ug/plate for TA1535 and TA1537 with S9
Untreated negative controls:
no
Negative solvent / vehicle controls:
no
True negative controls:
no
Positive controls:
yes
Positive control substance:
other:
Remarks:
2-Aminoanthracene 10ug/plate for WP2uvrA- with S9
Untreated negative controls:
no
Negative solvent / vehicle controls:
no
True negative controls:
no
Positive controls:
yes
Positive control substance:
benzo(a)pyrene
Remarks:
5 ug/plate for TA98
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
no
Positive control substance:
other:
Remarks:
Water
Details on test system and experimental conditions:
Summary
Salmonella typhimurium strains TA1535, TA1537, TA98, TA100 and Escherichia coli strain WP2uvrA- were treated with the test material using both the Ames plate incorporation and pre-incubation methods at up to seven dose levels, in triplicate, both with and without the addition of a rat liver homogenate metabolising system (10% liver S9 in standard co-factors). The dose range for the first experiment was determined in a preliminary toxicity assay and ranged between 5 and 5000 μg/plate, depending on bacterial strain type and presence or absence of S9-mix. The experiment was repeated on a separate day (pre-incubation method) using a similar dose range to Experiment 1, fresh cultures of the bacterial strains and fresh test material formulations. Additional dose levels and an expanded dose range were selected in both experiments in order to achieve both four non-toxic dose levels and the toxic limit of the test material.

Tester strains
The following strains were used:

Salmonella typhimurium TA1535, TA1537, TA98 and TA100
Escherichia coli WP2uvrA

The four strains of Salmonella used in the test were obtained either from the University of California, Berkeley, on culture discs, on 04 August 1995 or from Syngenta CTL, Alderley Edge, as frozen vials, on 20 March 2007. E. coli strain WP2uvrA- was obtained from the British Industrial Biological Research Association, on a nutrient agar plate, on 17 August 1987. All of the strains were stored at approximately ¯196°C in a Statebourne liquid nitrogen freezer, model SXR 34. Prior to the master strains being used, characterisation checks were carried out to confirm the amino-acid requirement, presence of rfa, R factors, uvrB or uvrA mutation and the spontaneous reversion rate (5). In this assay, overnight sub-cultures of the appropriate coded stock cultures were prepared in nutrient broth (Oxoid Limited; lot number 757012 03/14) and incubated at 37°C for approximately 10 hours. Each culture was monitored spectrophotometrically for turbidity with titres determined by viable count analysis on nutrient agar plates

Preparation of Test and Control Materials
The test material was fully miscible in sterile distilled water at 50 mg/ml in solubility checks performed in-house. Sterile distilled water was therefore selected as the vehicle. The test material was accurately weighed and approximate half-log dilutions prepared in sterile distilled water by mixing on a vortex mixer on the day of each experiment. Formulated concentrations were adjusted to allow for the stated impurity content (ethylene glycol at 38.5%) of the test material. Analysis for concentration, homogeneity and stability of the test material formulations is not a requirement of the test guidelines and was, therefore, not determined. This is an exception with regard to GLP and has been reflected in the GLP compliance statement.

Vehicle and positive controls were used in parallel with the test material. A solvent treatment group was used as the vehicle control and the positive control materials used in the series of plates without S9-mix were as follows:

N-ethyl-N'-nitro-N-nitrosoguanidine (without S9) abbreviated to ENNG
9-Aminoacridine (without S9) abbreviated to 9AA
4-Nitroquinoline-1-oxide (without S9) abbreviated to 4NQO
2-Aminoanthracene (with S9) abbreviated to 2AA
Benzo(a)pyrene (with S9) abbreviated to BP

Preliminary Toxicity test
In order to select appropriate dose levels for use in the main test, a preliminary test wascarried out to determine the toxicity of the test material. The concentrations tested were 0, 0.15, 0.5, 1.5, 5, 15, 50, 150, 500, 1500 and 5000 μg/plate. The test was performed by mixing 0.1 ml of bacterial culture (TA100 or WP2uvrA-), 2 ml of molten, trace histidine or tryptophan supplemented, top agar, 0.1 ml of test material formulation and 0.5 ml of S9-mix or phosphate buffer and overlaying onto sterile plates of Vogel-Bonner Minimal agar (30 ml/plate). Ten concentrations of the test material formulation and a vehicle control (sterile distilled water) were tested. In addition, 0.1 ml of the maximum concentration of the test material and 2 ml of molten, trace histidine or tryptophan supplemented, top agar were overlaid onto a sterile Nutrient agar plate in order to assess the sterility of the test material. After approximately 48 hours incubation at 37°C the plates were assessed for numbers of revertant colonies using a Domino colony counter and examined for effects on the growth of the bacterial background lawn

Mutation test - Experiment 1
Up to seven concentrations of the test material were assayed in triplicate against each tester strain, using the direct plate incorporation method. In the initial test, the toxicity of the test material yielded results that differed slightly from the preliminary toxicity test and consequently, there was an insufficient number of non-toxic dose levels for the Salmonella strains (predominantly in the absence of S9-mix). Therefore, part of the experiment was repeated using additional dose levels and expanded dose range. Dose ranges were allocated as follows:

Salmonella strains TA100, TA1535, TA98 (presence of S9-mix) and E.coli strain WP2uvrA- (absence and presence of S9-mix): 50, 150, 500, 1500, 5000 μg/plate.
Salmonella strains TA100, TA1535, TA98 (absence of S9-mix) and TA1537 (absence and presence of S9-mix): 5, 15, 50, 150, 500, 1500, 5000 μg/plate.

Additional dose levels and an expanded dose range were selected (where applicable) in order to achieve both four non-toxic dose levels and the toxiclimit of the test material.

Measured aliquots (0.1 ml) of one of the bacterial cultures were dispensed into sets of test tubes followed by 2.0 ml of molten, trace histidine or tryptophan supplemented, top agar, 0.1 ml of the test material formulation, vehicle or positive control and either 0.5 ml of S9-mix or phosphate buffer. The contents of each test tube were mixed and equally distributed onto the surface of Vogel-Bonner Minimal agar plates (one tube per plate). This procedure was repeated, in triplicate, for each bacterial strain and for each concentration of test material both with and without S9-mix.

All of the plates were incubated at 37°C for approximately 48 hours and the frequency of revertant colonies assessed using a Domino colony counter

Mutation test - Experiment 2
The second experiment was performed using fresh bacterial cultures, test material and control solutions. The test material dose range was amended slightly, following the results of Experiment 1, as follows:

Salmonella strains TA100, TA1535, TA98 (presence of S9-mix): 5, 15, 50, 150, 500, 1500, 5000 μg/plate.
E.coli strain WP2uvrA- (absence and presence of S9-mix): 15, 50, 150, 500, 1500, 5000 μg/plate.
Salmonella strains TA100, TA1535, TA98 (absence of S9-mix) and TA1537 (absence and presence of S9-mix): 1.5, 5, 15, 50, 150, 500, 1500 μg/plate

Additional dose levels and an expanded dose range were again selected in order to achieve both four non-toxic dose levels, the toxic limit of the test material and to account for the change in test methodology.

The test material formulations and vehicle control were dosed using the pre incubation method as follows: Measured aliquots (0.1 ml) of one of the bacterial cultures were dispensed into sets of test tubes followed by 0.5 ml of S9-mix or phosphate buffer and 0.1 ml of the vehicle or test material formulation and incubated for 20 minutes at 37°C with shaking at approximately 130 rpm prior to the addition of 2 ml of molten, trace histidine or tryptophan supplemented, top agar. The contents of the tube were then mixed and equally distributed on the surface of Vogel-Bonner Minimal agar plates (one tube per plate). This procedure was repeated, in triplicate, for each bacterial strain and for each concentration of test material both with and without S9-mix.

The positive and untreated controls were dosed using the standard plate incorporation method previously described..

All of the plates were incubated at 37°C for approximately 48 hours and the frequency of revertant colonies assessed using a Domino colony counter






Evaluation criteria:
The reverse mutation assay may be considered valid if the following criteria are met:

1. All tester strain cultures exhibit a characteristic number of spontaneous revertants per plate in the vehicle and untreated controls within historic norms for the laboratory
2. The appropriate characteristics for each tester strain have been confirmed, eg rfa cellwall mutation and pKM101 plasmid R-factor etc.
3. All tester strain cultures should be in the range of 1 to 9.9 x 109 bacteria per ml.
4. Each mean positive control value should be at least twice the respective vehicle control value for each strain, thus demonstrating both the intrinsic sensitivity of the tester strains to mutagenic exposure and the integrity of the S9 mix.
4. There should be a minimum of four non-toxic test material dose levels.
5. There should be no evidence of excessive contamination.

There are several criteria for determining a positive result, such as a dose-related increase in revertant frequency over the dose range tested and/or a reproducible increase at one or more concentrations in at least one bacterial strain with or without metabolic activation. Biological relevance of the results will be considered first, statistical methods, can also be used as an aid to evaluation, however, statistical significance will not be the only determining factor for a positive response.

A test material will be considered non mutagenic (negative) in the test system if the above criteria are not met.

Although most experiments will give clear positive or negative results, in some instances the data generated will prohibit a definitive judgement about the test material activity. Results of this type will be reported as equivocal.
Statistics:
Standard deviation only

Results and discussion

Test resultsopen allclose all
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
From 500 ug/plate absence of S9 and from 1500 ug/plate with S9
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
From 500 ug/plate absence of S9 and from 1500 ug/plate with S9
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
From 500 ug/plate absence of S9 and from 1500 ug/plate with S9
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
From 500 ug/plate absence of S9 and from 1500 ug/plate with S9
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

Preliminary Toxicity test

S9 Strain Dose ug/plate
  0 0.15 0.5 1.5 5 15 50 150 500 1500 5000
- TA100 93 115 120 110 109 134 118 108 140 129 154
+ TA100 99 70 91 89 87 151 144 130 115 154 135
- WP2uvrA- 42 31 23 27 34 23 37 29 34 19 30
+ WP2uvrA- 42 51 48 41 40 44 49 43 44 36 23

Experiment 1

Experiment One
S9 Mix Concn
(ug/plate)
Strain
TA100 TA1535 WP2uvrA TA98 TA1537
Count Mean (SD) Count Mean (SD) Count Mean (SD) Count Mean (SD) Count Mean (SD)
- 0 126 111
(13.1)
11 14
(3.8)
47 45
(3.8)
20 20
(1.5)
12 14
(4.4)
107 18 41 18 11
101 12 48 21 19
- 5 115 103
(10.7)
18 17
(2.6)
NT NT 27 22
(5.5)
7 10
(3.6)
94 14 16 9
101 19 22 14
- 15 110 104
(7.8)
10 12
(1.5)
NT NT 19 20
(1.5)
11 10
(1)
106 13 20 10
95 12 22 9
- 50 87 97
(21.5)
11 10
(1.5)
42 44
(2)
21 21
(3.5)
7 10
(4.6)
83 8 46 25 7
122 10 44 18 15
- 150 75 94
(16.8)
12 14
(2.1)
45 43
(4)
19 24
(4.2)
7 8
(1)
107 13 45 25 8
100 16 38 27 9
- 500 90 S 85
(5)
5 S 7
(2.5)
42 47
(4.6)
17 S 17
(4.5)
4 S 4
(2.5)
86 S 10 S 51 21 S 2 S
80 S 7 S 48 12 S 7 S
- 1500 54 S 47
(5.9)
7 S 11
(3.6)
40 42
(4)
3 S 2
(1)
1 V 2
(1.2)
45 S 14 S 47 1 S 3 V
43 S 12 S 40 2 S 1 V
- 5000 27 S 38
(9.9)
6 V 7
(2.1)
41 41
(3)
4 S 4
(1)
0 V 0
(0)
45 S 9 V 44 3 S 0 V
43 S 5 V 38 5 S 0 V
- Name ENNG ENNG ENNG 4NQO 9AA
Concn
(ug/plate)
3 5 2 0.2 80
 Results 553 469
(73.9)
198 190
(14.7)
285 280
(9.5)
152

154
(14.6)

1154 1078
(66.1)
438 173 286 140 1038
415 199 269 169 1041

Where S = Sparse bacterial background lawn, V= Very sparse bacterial background lawn

Experiment One
S9 Mix Concn
(ug/plate)
Strain
TA100 TA1535 WP2uvrA TA98 TA1537
Count Mean (SD) Count Mean (SD) Count Mean (SD) Count Mean (SD) Count Mean (SD)
+ 0 97 99
(7.6)
9 13
(3.8)
48 48
(3.5)
29 32
(3.6)
15 12
(3.1)
92 15 44 36 11
107 16 51 31 9
+ 5 NT NT NT NT NT NT NT NT 12 13
(3.1)
16
10
+ 15 NT NT NT NT NT NT NT NT 12 13
(4.6)
18
9
+ 50 108 95
(13)
13 12
(1.2)
35 42
(6.2)
31 31
(4.5)
12 11
(1.2)
96 11 47 27 10
82 13 44 36 10
+ 150 89 96
(6.5)
13 13
(1.5)
46

49
(2.5)

31 30
(3.1)
12 11
(3.2)
96 15 49 27 13
102 12 51 36 7
+ 500 93 86
(6.6)
12 13
(1.2)
59 47
(11.1)
41 37
(4.6)
9 11
(2.1)
85 14 37 38 13
80 12 45 32 12
+ 1500 55 67
(10.6)
16 13
(2.5)
43 42
(4.6)
31 25
(5.3)
3 S 3
(1)
75 11 37 23 4 S
71 13 46 21 2 S
+ 5000 40 S 40
(11.5)
8 S 10
(3.8)
48 48
(3)
11 S 8
(4.2)
3 S 3
(1.5)
52 S 7 S 51 9 S 1 S
29 S 14 S 45 3 S 4 S
- Name 2AA 2AA 2AA BP 2AA
Concn
(ug/plate)
1 2 10 5 2
 Results 1656 1207
(431.7)
236 236
(13)
223 235
(13.9)
229 238
(27.6)
246 246
(9.5)
1169 223 250 216 236
795 249 231 269 255

Where S = Sparse bacterial background lawn

Experiment 2

Experiment Two
S9 Mix Concn
(ug/plate)
Strain
TA100 TA1535 WP2uvrA TA98 TA1537
Count Mean (SD) Count Mean (SD) Count Mean (SD) Count Mean (SD) Count Mean (SD)
- 0 130 117
(11.6)
19 17
(3.5)
32 31
(2.1)
18 21
(3.1)
11 14
(3.8)
109 13 29 22 12
111 19 33 24 18
- 1.5 128 117
(13.6)
19 18
(1.7)
NT NT 18 18
(0.6)
12 13
(2.6)
102 16 18 16
122 19 19 11
- 5 107 114
(7)
21 15
(6)
NT NT 20 21
(1)
15

13
(2.5)

114 9 22 13
121 16 21 10
- 15 111 101
(8.5)
14 17
(3.1)
36 33
(5.2)
21 21
(4.5)
12 14
(1.5)
98 16 27 25 14
95 20 36 16 15
- 50 95 88
(5.9)
16 18
(2.9)
29 29
(2.5)
20 21
(1)
9 12
(2.6)
84 16 31 21 13
86 21 26 22 14
- 150 101 109
(7.2)
18 17
(3.6)
31 30
(2.3)
20 19
(3.6)
9 11
(2.5)
114 13 27 15 11
113 20 31 22 14
- 500 98 S 99
(0.6)
16 15
(1.2)
24 26
(1.7)
20 16
(3.5)
8 S 6
(1.7)
99 S 14 27 16 5 S
99 S 16 27 13 5 S
- 1500 47 S 55
(9.1)
4 S 4
(0.6)
23 26
(2.1)
4 S

5
(1.2)

2 S 3
(2.1)
54 S 5 S 27 6 S 5 S
65 S 4 S 29 4 S 1 S
- 5000 NT NT NT NT 29 33
(4)
NT NT NT NT
37
32
- Name ENNG ENNG ENNG 4NQO 9AA
Concn
(ug/plate)
3 5 2 0.2 80
 Results 503 497
(13.7)
64 162
(85.3)
262 283
(22.6)
114 116
(5.3)
2297 2530
(315.3)
481 216 280 122 3889
506 207 307 112 2405

Where S = Sparse bacterial background lawn

Experiment Two
S9 Mix Concn
(ug/plate)
Strain
TA100 TA1535 WP2uvrA TA98 TA1537
Count Mean (SD) Count Mean (SD) Count Mean (SD) Count Mean (SD) Count Mean (SD)
+ 0 117 109
(6.8)
18 18
(0.6)
36 36
(4)
26 27
(1.7)
13 12
(2.1)
107 19 32 26 10
104 18 40 29 14
+ 1.5 NT NT NT NT NT NT NT NT 14 14
(0.6)
14
15
+ 5 114 102
(12)
18 16
(2.1)
NT NT 31 27
(3.6)
12 12
(0.6)
90 15 24 12
102 14 26 13
+ 15 118 112
(5.1)
15 14
(1.2)
38 39
(2.1)
28 25
(3.5)
11 12
(2.6)
111 13 37 21 10
108 15 41 25 15
+ 50 103 112
(10.7)
21 19
(1.5)
23 34
(10.2)
25 25
(2)
11 12
(1.5)
124 19 36 27 14
110 18 43 23 12
+ 150 125 112
(11.4)
21 18
(3.1)
38 32
(5.6)
30 27
(3.5)
12 12
(1.5)
107 15 31 23 11
104 19 27 27 14
+ 500 99 112
(12.1)
14 13
(2.6)
37 35
(3.2)
23 25
(4.4)
14 13
(1.2)
123 15 31 22 12
113 10 36 30 12
+ 1500 97 S 108
(9.8)
14 18
(4)
42 36
(5.5)
14 15
(2.1)
5 S 8
(3)
114 S 18 33 17 8 S
114 S 22 32 13 11 S
+ 5000 57 S 54
(3)
13 S 12
(0.6)
31 32
(1.5)
4 S 4
(1.5)
NT NT
54 S 12 S 32 6 S
51 S 12 S 34 3 S
+ Name 2AA 2AA 2AA BP 2AA
Concn
(ug/plate)
1 2 10 5 2
 Results 629 801
(157.7)
288 292
(15.4)
143 130
(11.9)
180 189
(18.8)
100 95
(5.5)
939 309 120 177 89
834 279 126 211 95

Where S = Sparse bacterial background lawn

Note History profile for vehichle (Distilled water) and positive controls for 2008 and 2009 are available and indicate that the results reported here for these controls are within historic norms for the laboratory.

Applicant's summary and conclusion

Conclusions:
Interpretation of results:
negative with metabolic activation
negative without metabolic activation

The test material (PR-4758) was considered non-mutagenic under the conditions of the assay. The sensitivity of the assay and the efficacy of the S9-mix were validated as the vehicle (sterile distilled water) control plates gave counts of revertant colonies within the normal range. All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies, both with or without metabolic activation.
Executive summary:

At the request of Nalco Limited UK, Harlan laboratories performed a Bacterial reverse mutation assay on PR-4758. The study was conducted in accordance with Good laboratory practise.The test method was designed to be compatible with the guidelines for bacterial mutagenicity testing published by the major Japanese Regulatory Authorities including METI, MHLW and MAFF, the OECD Guidelines for Testing of Chemicals No. 471 "Bacterial Reverse Mutation Test", Method B13/14 of Commission Regulation (EC) number 440/2008 of 30 May 2008 and the USA, EPA (TSCA) OPPTS harmonized guidelines.


 


Salmonella typhimuriumstrains TA1535, TA1537, TA98, TA100 and Escherichia coli strain WP2uvrA- were treated with the test material using both the Ames plate incorporation and pre-incubation methods at up to seven dose levels, in triplicate, both with and without the addition of a rat liver homogenate metabolising system (10% liver S9 in standard co-factors). The dose range for the first experiment was determined in a preliminary toxicity assay and ranged between 5 and 5000 μg/plate, depending on bacterial strain type and presence or absence of S9-mix.


 


The experiment was repeated on a separate day (pre-incubation method) using a similar dose range to Experiment 1, fresh cultures of the bacterial strains and fresh test material formulations. Additional dose levels and an expanded dose range were selected in both experiments in order to achieve both four non-toxic dose levels and the toxic limit of the test material.


 


The vehicle (sterile distilled water) control plates gave counts of revertant colonies within the normal range. All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies, both with or without metabolic activation. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated. The test material caused a visible reduction in the growth of the bacterial background lawns of all of the Salmonella strains, initially from 500 and 1500 μg/plate, in the absence and presence of S9-mix, respectively. No toxicity was noted for Escherichia coli strain WP2uvrA- at any test material dose level. The sensitivity of the tester strains to the toxicity of the test material varied slightly between strain type, exposures with or without S9-mix and experiment number. The test material was, therefore, either tested up to the maximum recommended dose level of 5000 μg/plate or the toxic limit, depending on bacterial strain type and experiment number. No test material precipitate was observed on the plates at any of the doses tested in either the presence or absence of S9-mix. No significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test material, either with or without metabolic activation or exposure method. PR-4758 was considered non-mutagenic under the conditions of the assay.